- Report
- March 2025
- 363 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- September 2024
- 255 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2023
- 197 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- March 2022
- 120 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- January 2023
- 232 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2021
- 103 Pages
United States
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Book
- June 2016
- 360 Pages
Biological Warfare (BW) is a form of warfare that uses biological agents to cause harm or death to humans, animals, and plants. BW is a major component of biodefense, which is the practice of protecting against biological threats. BW is a growing concern due to the potential for a wide range of biological agents to be used in an attack. BW agents can be spread through the air, water, food, or contact with infected individuals.
The BW market is a rapidly growing sector of the biodefense industry. Companies in this market are focused on developing and producing products to protect against BW agents. These products include vaccines, diagnostic tests, decontamination systems, and protective gear. Companies are also developing technologies to detect and respond to BW threats.
Some companies in the BW market include Emergent BioSolutions, DynPort Vaccine Company, and BioThrax. Other companies include Cangene Corporation, PharmAthene, and SIGA Technologies. Show Less Read more